Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 157Gastrointestinal 102Head & Neck 81Breast 77Genitourinary 76Dermatologic 65Gynecologic 62Other solid neoplasm 39Tumor-Agnostic 25Sarcoma 20CNS 20Lymphoid 18Endocrine 7Other hematologic neoplasm 5NET 2Plasma cell 1Other 1Myeloid 1Classical hematology 1

Conditions

Sexual Dysfunction, Physiological 1Eunuchism 1Erectile Dysfunction 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Tirzepatide 5Educational Status 4naldemedine 3Methods 3Interviews as Topic 3Early Intervention, Educational 3semaglutide 2Tablets 2Standard of Care 2Specimen Handling 2Radiotherapy 2Paclitaxel 2Observation 2Mouthwashes 2Metformin 2Exercise 2Counseling 2Cisplatin 2Carboplatin 2trametinib 1tempol 1sotorasib 1selpercatinib 1polyethylene glycol 3350 1pembrolizumab 1osimertinib 1naloxegol 1mirabegron 1maltodextrin 1ma zi ren wan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × pembrolizumab × Other × Clear all
NCT06532149 2024-08-09

EROS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
80 enrolled
OtherThoracic

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡